As a result, we hypothesize that inhibiting the cGAS-STING signaling pathway may serve as a novel therapeutic target for managing HD, as it promotes the microglial activation via the release of inflammatory cytokines, resulting in the production of more cytokines and chemokines, which in turn induces neuronal degeneration in the brain. Here, CGAS is linked to Huntington disease.